• Back to miR-145-5p

• Papadopoulos, Emmanuel I., et al. "Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype." Biological chemistry 397.6 (2016): 529-539.
• Li, Jialu, et al. "Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma." Scientific reports 5 (2015): 12921.
• Inamoto, Teruo, et al. "A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder." Disease Markers 2018 (2018).
• Zhang, Hui, et al. "Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer." Oncology letters 13.2 (2017): 669-676.
• Zhao, Hua, et al. "Serum microRNA profiling in patients with glioblastoma: a survival analysis." Molecular cancer 16.1 (2017): 59.
• Goto, Yusuke, et al. "Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer." British journal of cancer 117.3 (2017): 409.
• Zhang, Ming, et al. "Circulating MicroRNA-145 is associated with acute myocardial infarction and heart failure." Chinese medical journal 130.1 (2017): 51.
• Toro, Rocío, et al. "Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy." Journal of Molecular Medicine 96.8 (2018): 845-856
• Gan, C. S., C. W. Wang, and K. S. Tan. "Circulatory microRNA-145 expression is increased in cerebral ischemia." Genet Mol Res 11.1 (2012): 147-152.